Novavax (NVAX) stock moves higher Thursday morning despite releasing mixed fourth quarter results, beating on revenue estimates while seeing year-over-year declines. Yahoo Finance senior health ...

Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute. This post was written by Naomi Buchanan. Novavax (NVAX) stock moves higher Thursday morning ...

In the closing of the recent trading day, Novavax (NVAX) stood at $7.91, denoting a -0.57% change from the preceding trading day.

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

NVAX) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by taking the expected future cash flows and discounting them to their ...

Novavax (NVAX) stock moves higher Thursday morning despite releasing mixed fourth quarter results, beating on revenue estimates while seeing year-over-year declines. Yahoo Finance senior health ...

Here at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is ...

NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that the Company granted a non- qualified stock option and restricted stock units to ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

Novavax (NVAX) stock moves higher Thursday morning despite releasing mixed fourth quarter results, beating on revenue estimates while seeing year-over-year declines. Yahoo Finance senior health ...